Perindopril arginine/amlodipine TAD 5 mg/5 mg tablets Ireland - English - HPRA (Health Products Regulatory Authority)

perindopril arginine/amlodipine tad 5 mg/5 mg tablets

tad pharma gmbh - perindopril arginine; amlodipine - tablet - perindopril and amlodipine

Perindopril New Zealand - English - Medsafe (Medicines Safety Authority)

perindopril

clinect nz pty limited - perindopril erbumine 2mg - tablet - 2 mg - active: perindopril erbumine 2mg excipient: lactose magnesium stearate - perindopril is indicated for: · the treatment of hypertension.

Perindopril New Zealand - English - Medsafe (Medicines Safety Authority)

perindopril

clinect nz pty limited - perindopril erbumine 4mg - tablet - 4 mg - active: perindopril erbumine 4mg excipient: lactose magnesium stearate - perindopril is indicated for: · the treatment of hypertension.

Perindopril New Zealand - English - Medsafe (Medicines Safety Authority)

perindopril

clinect nz pty limited - perindopril erbumine 8mg - tablet - 8 mg - active: perindopril erbumine 8mg excipient: lactose magnesium stearate - perindopril is indicated for: · the treatment of hypertension.

APO-Perindopril Arginine/Amlodipine 5/5 perindopril arginine 5 mg and amlodipine (as besilate) 5 mg uncoated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-perindopril arginine/amlodipine 5/5 perindopril arginine 5 mg and amlodipine (as besilate) 5 mg uncoated tablet blister pack

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 6.94 mg (equivalent: amlodipine, qty 5 mg); perindopril arginine, quantity: 5 mg - tablet - excipient ingredients: microcrystalline cellulose; colloidal anhydrous silica; magnesium stearate; croscarmellose sodium - perindopril arginine and amlodipine combination tablet is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

APO-Perindopril Arginine/Amlodipine 5/10 perindopril arginine 5 mg and amlodipine (as besilate) 10 mg uncoated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-perindopril arginine/amlodipine 5/10 perindopril arginine 5 mg and amlodipine (as besilate) 10 mg uncoated tablet blister pack

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg); perindopril arginine, quantity: 5 mg - tablet - excipient ingredients: magnesium stearate; croscarmellose sodium; colloidal anhydrous silica; microcrystalline cellulose - perindopril arginine and amlodipine combination tablet is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

APO-Perindopril Arginine/Amlodipine 10/10 perindopril arginine 10 mg and amlodipine (as besilate) 10 mg uncoated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-perindopril arginine/amlodipine 10/10 perindopril arginine 10 mg and amlodipine (as besilate) 10 mg uncoated tablet blister pack

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg); perindopril arginine, quantity: 10 mg - tablet - excipient ingredients: microcrystalline cellulose; croscarmellose sodium; colloidal anhydrous silica; magnesium stearate - perindopril arginine and amlodipine combination tablet is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

APO-Perindopril Arginine/Amlodipine 10/5 perindopril arginine 10 mg and amlodipine (as besilate) 5 mg uncoated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-perindopril arginine/amlodipine 10/5 perindopril arginine 10 mg and amlodipine (as besilate) 5 mg uncoated tablet blister pack

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 6.94 mg; perindopril arginine, quantity: 10 mg - tablet - excipient ingredients: microcrystalline cellulose; croscarmellose sodium; colloidal anhydrous silica; magnesium stearate - perindopril arginine and amlodipine combination tablet is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

APO-PERINDOPRIL perindopril erbumine 8mg tablets blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-perindopril perindopril erbumine 8mg tablets blister pack

arrotex pharmaceuticals pty ltd - perindopril erbumine, quantity: 8 mg - tablet, uncoated - excipient ingredients: lactose; magnesium stearate - treatment of hypertension. treatment of heart failure. in such patients it is recommended that perindopril be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril have not been demonstrated for new york heart association category iv patients). patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of nonfatal myocardial infarction or cardiac arrest.

APO-PERINDOPRIL perindopril erbumine 4mg tablets blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-perindopril perindopril erbumine 4mg tablets blister pack

arrotex pharmaceuticals pty ltd - perindopril erbumine, quantity: 4 mg - tablet, uncoated - excipient ingredients: lactose; magnesium stearate - treatment of hypertension. treatment of heart failure. in such patients it is recommended that perindopril be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril have not been demonstrated for new york heart association category iv patients). patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of nonfatal myocardial infarction or cardiac arrest.